The IgG Bartonella test measures antibodies against Bartonella species, a group of bacteria transmitted by ticks, fleas, or scratches from infected animals (especially cats). Bartonella henselae and Bartonella quintana are the most common human pathogens. Infection can lead to cat scratch disease, trench fever, or tick-borne bartonellosis, which may cause persistent systemic or neurological symptoms. What IgG Bartonella Means IgG antibodies generally appear weeks after infection and can remain detectable for months or years. A positive IgG result usually indicates past exposure or immune memory rather than an active infection. Because IgM antibodies reflect recent or acute infection, IgG testing is more useful for identifying later or chronic immune responses. Clinical Importance Testing for IgG Bartonella can be useful in patients with: Persistent fatigue, fever, or swollen lymph nodes Neurological complaints such as headaches, neuropathy, or cognitive issues Joint or muscle pain that overlaps with other tick-borne illnesses A history of tick bites, cat exposure, or flea bites in areas where Bartonella is present Suspected co-infections, since Bartonella is often found alongside Lyme disease and Babesia Patient Takeaway A positive IgG Bartonella result means your immune system has previously recognized Bartonella, suggesting prior exposure or infection. However, IgG alone does not confirm whether the infection is still active, as antibodies may persist long after initial illness. Your healthcare provider will interpret the result alongside your symptoms, medical history, and other diagnostic tests (such as IgM, PCR, or culture-based methods). If the result is equivocal (borderline), antibody levels are close to the cutoff and not clearly positive or negative. In these cases, repeat or confirmatory testing is usually recommended.
IgG to the Epstein–Barr Virus Early Antigen (EA) helps evaluate whether the virus may have been active or reactivated at some point. Early Antigen is a protein produced during the early phase of EBV replication. While most people only develop long-term antibodies to EBV’s Viral Capsid Antigen (VCA) and EBNA proteins, some individuals also develop EA IgG. EA IgG is sometimes used in conjunction with other EBV markers (VCA IgM, VCA IgG, EBNA IgG) to help understand patterns of: Past EBV infection Possible reactivation Chronic or recurrent EBV activity However, EA IgG alone does not diagnose acute EBV and often requires correlation with multiple markers. What It Means When Your EA IgG Result Is Within the Reference Range (Negative) A negative or normal IgG Early Antigen result means there is no evidence of immune activity directed at EBV’s Early Antigen. In practical terms, this indicates: No sign of recent EBV reactivation No indication of active viral replication No detectable EA-specific immune memory Because EA IgG is not always produced during routine EBV infections, many healthy individuals remain EA IgG negative even if they had mononucleosis or another EBV infection years earlier. A negative EA IgG result is therefore common and expected. When EA IgG is within the reference range: EBV is not actively replicating There is no laboratory support for ongoing or chronic EBV activity Past EBV exposure (if present) is considered stable and inactive This finding is especially meaningful when paired with negative EBV VCA IgM and negative or stable EBV IgG markers.
IgG EB Nuclear Antigen (EBNA IgG) measures long-term antibodies produced after infection with Epstein–Barr virus (EBV). EBNA IgG is a key marker because it typically appears later in the infection, often several months after the initial illness, and then remains detectable for life. For this reason, EBNA IgG is considered one of the most reliable indicators of past EBV infection. When positive, it helps confirm that someone has previously had EBV and has developed lasting immune memory to the virus. Clinicians often use EBNA IgG together with VCA IgG, VCA IgM, and Early Antigen (EA) to understand whether an infection is recent, past, or possibly reactivated. What It Means When Your EBNA IgG Result Is Within the Reference Range (Negative) A negative or normal EBNA IgG result means there is no detectable antibody response to the EBV Nuclear Antigen. This typically indicates: No evidence of a past EBV infection, or The infection was very recent, and EBNA antibodies have not yet appeared (less common), or Antibody levels are below the detection threshold of the test. Because EBNA IgG usually becomes positive months after infection and remains elevated for life, most adults who have ever had EBV will test positive. A negative result is therefore most common in: Young children Individuals who have never been exposed to EBV People being tested early in the course of a suspected new infection When EBNA IgG is within the reference range, and other EBV markers (VCA IgG, EA IgG, VCA IgM) are also negative, this strongly suggests no prior EBV infection.
The IgG Ehrlichia test measures antibodies against Ehrlichia species, bacteria transmitted by ticks that cause ehrlichiosis, a potentially serious tick-borne illness. The two main human pathogens are Ehrlichia chaffeensis (human monocytic ehrlichiosis, HME) and Ehrlichia ewingii. Infections can lead to fever, chills, muscle aches, headache, and sometimes severe complications if untreated. What IgG Ehrlichia Means IgG antibodies typically develop within 2–4 weeks after infection and may remain present for months or years. A positive IgG result usually indicates past exposure or immune memory to Ehrlichia. Since IgM antibodies reflect more recent infection, IgG testing is most useful for assessing later or past stages of ehrlichiosis. Clinical Importance Testing for IgG Ehrlichia can be important in patients with: Unexplained fever, fatigue, headache, or muscle pain following a tick bite Low white blood cell counts, low platelets, or abnormal liver tests often seen in ehrlichiosis Persistent or relapsing symptoms after tick exposure in endemic regions Suspected co-infections with other tick-borne pathogens such as Borrelia (Lyme disease) or Babesia Patient Takeaway A positive IgG Ehrlichia result means your immune system has recognized the bacteria at some point, suggesting prior exposure or infection. This does not always mean the infection is currently active, since IgG antibodies may persist long-term. Your healthcare provider will interpret this result together with your symptoms, tick exposure history, and other test results (including IgM, PCR, or blood smear) to determine whether ehrlichiosis is active or past. If your result is reported as equivocal (borderline), antibody levels are close to the cutoff and not clearly positive or negative. In these cases, repeat or confirmatory testing is often recommended.
IgG Epstein–Barr Virus Viral Capsid Antigen (EBV VCA IgG) measures long-term antibodies produced after infection with Epstein–Barr virus (EBV)—one of the most common human viruses. EBV typically causes infectious mononucleosis (“mono”) but can also produce very mild or even unnoticed infections, especially in children. VCA IgG antibodies usually appear a few weeks after infection and remain detectable for life. Because of this, EBV VCA IgG is a reliable marker for determining whether someone has been infected with EBV at any point in the past. This marker is most informative when combined with: EBV VCA IgM EBV Early Antigen (EA) EBV EBNA IgG Together, these help distinguish past infection, recent infection, and possible viral reactivation. What It Means When Your IgG EBV VCA Result Is Within the Reference Range (Negative) A negative or normal EBV VCA IgG result means there is no detectable evidence of a past EBV infection. Your immune system is not showing long-term antibodies to EBV’s Viral Capsid Antigen. When EBV VCA IgG falls within the reference range: You have not been previously infected with EBV, or Your antibody level is below the test’s detection limit, which is uncommon but possible in early infection. There is no indication of prior mononucleosis, nor of past EBV exposure. EBV is not currently active based on this antibody alone. Most adolescents and adults test positive for EBV IgG because past exposure is extremely common. A negative result simply means you have not developed lasting EBV antibodies yet.
IgG HHV-6 Herpe Type-6
The IgG Immunodominant Peptide C6 (P. C6) test detects antibodies against a highly conserved region of the VlsE protein from Borrelia burgdorferi, the main bacterium that causes Lyme disease. The C6 peptide is considered an immunodominant epitope—a portion of the protein that triggers a strong and reliable immune response across different strains of Borrelia. What IgG P. C6 Means IgG antibodies to C6 usually appear several weeks after infection and remain detectable during later stages of Lyme disease. A positive result suggests past or ongoing immune recognition of Borrelia, making this test useful for identifying later-stage or persistent infection. Because C6 is highly conserved, the test can detect antibody responses across different Borrelia species, improving diagnostic sensitivity. Clinical Importance Testing for IgG P. C6 can be particularly valuable in: Patients with suspected Lyme disease who are beyond the early infection window Individuals with joint, neurological, or chronic symptoms linked to Lyme Confirmatory testing, as C6 is often used alongside other Borrelia markers (OspC, OspA, VlsE) to increase accuracy Patient Takeaway A positive IgG P. C6 result means your immune system has recognized the C6 peptide of Borrelia, suggesting exposure to the Lyme disease bacterium. This does not always prove an active infection, since IgG can persist after prior illness, but it is considered a reliable marker of Borrelia exposure. Your healthcare provider will compare this result with your symptoms, tick exposure history, and other Lyme disease tests for a complete interpretation. If your result is equivocal (borderline), antibody levels are close to the cutoff and the finding is uncertain. In this case, repeat or additional confirmatory testing may be recommended.
The IgG LFA Antigen + CK10 test evaluates long-term antibody responses to both Borrelia antigens (using a lateral flow assay, or LFA) and Cytokeratin 10 (CK10), a structural protein found in epithelial tissues such as the skin. This combined test helps clinicians explore the connection between infection-driven immune responses and autoimmune reactivity. What IgG LFA Antigen + CK10 Means IgG antibodies usually appear weeks after infection and remain detectable long-term as part of immune memory. A positive IgG LFA antigen result suggests past exposure to Borrelia or related tick-borne pathogens. The detection of IgG antibodies against CK10 may point toward autoimmune activity involving epithelial tissues, which can sometimes develop after infection-triggered immune responses. Clinical Importance This test may be most useful in patients who have: Chronic or unexplained skin symptoms such as rashes, blistering, or inflammatory dermatoses Persistent immune symptoms following a suspected tick-borne infection Overlap of infection and autoimmunity, where Borrelia exposure may have triggered autoimmune processes Complex or long-standing multi-system symptoms that are difficult to classify with single-marker tests Patient Takeaway A positive IgG LFA Antigen + CK10 result indicates that your immune system has previously recognized Borrelia antigens and may also be reacting to CK10, a self-protein in epithelial tissues. This combination can provide important clues about both past infection and possible autoimmune involvement. Your healthcare provider will interpret the result in the context of your symptoms, medical history, and additional laboratory findings. If your test is reported as equivocal (borderline), antibody levels are close to the cutoff and not clearly positive or negative. In this case, repeat or confirmatory testing is usually recommended.
What is it? The IgG Outer Surface Proteins A and C (OspA & OspC) test is a blood test that measures your immune system’s production of IgG antibodies against specific proteins on the surface of Borrelia burgdorferi, the bacteria that causes Lyme disease. Outer Surface Proteins (Osp) are molecules the bacteria use to survive and infect humans: OspA helps the bacteria persist in ticks. OspC plays a key role in establishing infection in people. When your immune system encounters Borrelia burgdorferi, it may produce IgG antibodies targeting these proteins. Detecting these antibodies can help provide clues about whether your body has mounted a response to Lyme disease. Why is this marker important? A positive IgG OspA/OspC result suggests that your body has been exposed to the Lyme bacteria in the past and created antibodies. IgG antibodies usually appear weeks to months after infection, so they are more commonly seen in later or persistent stages of Lyme disease. This test is often used alongside other Lyme disease tests (such as IgM antibodies, ELISA, or Western blot) to give a more complete diagnostic picture. How to interpret results Elevated IgG OspA/OspC Suggests past exposure or possible ongoing infection with Borrelia burgdorferi Typically appears in later or chronic phases of the disease Levels may stay elevated for years, even after successful treatment Normal or Negative IgG OspA/OspC May mean no prior exposure Could also mean antibodies have not yet developed (common in very early Lyme disease, known as the “window period”) Repeat testing may be considered if symptoms suggest Lyme but the initial test is negative Symptoms often linked with Lyme disease People who test positive for Lyme markers often recall symptoms such as: Early stage: bull’s-eye rash (erythema migrans), fever, chills, muscle aches, fatigue Later stage: joint pain, headaches, nerve pain, memory or concentration problems, irregular heartbeat What can affect this test? Stage of infection: IgG develops later, so it’s not reliable for early detection Immune system health: Those with weakened immunity may not produce strong antibodies Previous infection: IgG antibodies may persist long after treatment and recovery What to do if your results are elevated An elevated result by itself does not confirm active Lyme disease. Your healthcare provider will interpret these findings together with: Your symptoms and medical history Other Lyme tests (IgM, ELISA, Western blot, or PCR) Possible tick exposure in Lyme-endemic areas If Lyme disease is suspected, your doctor may recommend antibiotic treatment tailored to the stage and presentation of the illness. Key takeaway The IgG OspA/OspC test shows whether your immune system has produced longer-term antibodies to Lyme disease bacteria. A positive result indicates past or possible ongoing exposure, but it does not by itself prove an active infection. Your doctor will combine this result with your symptoms, exposure history, and additional tests to make the most accurate diagnosis and treatment plan.
The IgG OspE test measures antibodies against Outer Surface Protein E (OspE) of Borrelia burgdorferi, one of the proteins that help the bacterium evade the immune system and persist in the body. OspE belongs to the Erp (OspE-related proteins) family, which plays a key role in protecting Borrelia from complement-mediated killing by binding to host factor H. What IgG OspE Means IgG antibodies against OspE typically develop weeks to months after infection and may remain detectable long after exposure. A positive IgG OspE result indicates past immune recognition of Borrelia, which can support the diagnosis of later or persistent Lyme disease. Because OspE helps Borrelia survive in the bloodstream, IgG detection may be especially relevant in patients with disseminated or chronic forms of infection. Clinical Importance Testing for IgG OspE may be most useful in patients with: Persistent or late-stage Lyme symptoms such as arthritis, fatigue, or neurological complaints Evidence of Borrelia dissemination, where immune evasion mechanisms are important Chronic or relapsing illness following a history of tick exposure in endemic regions Suspected co-infections, where broader immune profiling improves diagnostic accuracy Patient Takeaway A positive IgG OspE result suggests your immune system has previously recognized this Borrelia surface protein, pointing to past or ongoing exposure. However, IgG antibodies can remain in the body long after the initial infection, so the result does not confirm whether the infection is still active. Your healthcare provider will interpret the result alongside your symptoms, clinical history, and additional Lyme disease markers (such as OspC, OspA, or VlsE/C6). If your IgG OspE result is equivocal (borderline), antibody levels are near the cutoff and not clearly positive or negative. In such cases, repeat or confirmatory testing may be recommended.
The IgG VmpE test measures antibodies against Variable Major Protein E (VmpE), a surface protein produced by Borrelia burgdorferi, the bacterium that causes Lyme disease. VmpE belongs to a family of variable major proteins (Vmps) that the bacteria can change through a process called antigenic variation. This ability allows Borrelia to evade immune detection and sometimes persist in the body. What IgG VmpE Means IgG antibodies generally appear weeks after infection and remain detectable long-term as part of immune memory. A positive IgG VmpE result suggests past or ongoing immune recognition of Borrelia. Because VmpE changes its structure to avoid the immune system, IgG reactivity may reflect exposure during persistent or relapsing stages of infection. This test complements other Borrelia markers (such as OspC and VlsE) by giving additional insight into how the immune system responds to Borrelia’s evasion strategies. Clinical Importance Testing for IgG VmpE may be useful in patients with: Chronic or relapsing Lyme symptoms, such as fatigue, joint pain, or neurological issues Suspected persistent infection, where Borrelia may continue to vary its surface proteins Unexplained immune activity after a history of tick exposure in endemic areas Patient Takeaway A positive IgG VmpE result means your immune system has previously recognized this variable Borrelia protein. This points to prior or ongoing exposure, but IgG antibodies alone cannot confirm an active infection, since they may persist long after the illness. Your healthcare provider will interpret the result together with your symptoms, medical history, and other Lyme disease markers. If the IgG VmpE result is equivocal (borderline), antibody levels are close to the cutoff and not clearly positive or negative. In this case, repeat or confirmatory testing is usually recommended.
What is IgG (Immunoglobulin G)? Immunoglobulin G (IgG) is the most abundant type of antibody in your blood and body fluids. It plays a central role in your immune system’s defense against infections, especially bacterial and viral pathogens. IgG antibodies are produced by B cells in response to foreign invaders. Once produced, they help neutralize pathogens, trigger other immune cells to attack, and form long-term immune memory—which is the basis of how vaccines work. The “RDL” in the test name refers to Rheumatology Diagnostics Laboratory, a specialized lab that often analyzes autoimmune and immunologic markers. Why is IgG tested? An IgG blood test helps evaluate how well your immune system is functioning. It may be ordered to investigate: Frequent or severe infections (suggesting immunodeficiency) Autoimmune conditions (suggesting overactivity or dysregulation) Chronic inflammation Monoclonal gammopathies or plasma cell disorders (e.g., multiple myeloma) Monitoring after immunoglobulin therapy or bone marrow transplant It’s also commonly measured alongside IgA and IgM as part of a quantitative immunoglobulin panel. What does a high IgG result mean? An elevated IgG level can indicate that your immune system is overactive or responding to chronic infection, inflammation, or autoimmune disease. Common causes of elevated IgG include: 1. Chronic Infections Tuberculosis Chronic hepatitis (especially hepatitis B or C) HIV/AIDS (in some phases) Fungal or parasitic infections 2. Autoimmune Diseases Lupus (SLE) Rheumatoid arthritis Autoimmune hepatitis Sarcoidosis 3. Chronic Inflammation or Immune Activation Chronic allergic conditions Inflammatory bowel disease (IBD) Chronic lung or liver disease 4. Monoclonal or Polyclonal Gammopathies Multiple myeloma or MGUS (monoclonal gammopathy of undetermined significance) In these cases, IgG may be elevated due to uncontrolled production by abnormal plasma cells. What does a low IgG result mean? A low IgG level may suggest that your immune system can’t produce enough antibodies, leaving you vulnerable to infections. Possible causes of low IgG include: 1. Primary Immunodeficiencies Common Variable Immunodeficiency (CVID) X-linked agammaglobulinemia Selective IgG subclass deficiency 2. Secondary Immunodeficiencies Chronic lymphocytic leukemia (CLL) Immunosuppressive therapies (e.g., chemotherapy, corticosteroids) Nephrotic syndrome (IgG lost in urine) Protein-losing enteropathy Bone marrow failure or transplant People with low IgG often have frequent respiratory infections, chronic sinusitis, or pneumonia and may require immunoglobulin replacement therapy (IVIG or SCIG). What does a normal IgG result mean? A normal IgG level suggests your immune system is producing antibodies appropriately and there’s no current evidence of a major immune deficiency or hyperactivity. However, normal levels don’t always rule out disease—clinical symptoms and other lab findings are essential to the full picture. What happens next if your IgG is abnormal? If IgG is elevated: Your doctor may order additional testing, such as: IgA, IgM, and IgE levels Autoimmune panels (ANA, RF, dsDNA) Protein electrophoresis (SPEP/UPEP) to detect monoclonal spikes Infectious disease screening You may be referred to a rheumatologist, infectious disease specialist, or hematologist If IgG is low: Your provider may: Order IgG subclass testing Evaluate your infection history Consider immunoglobulin replacement therapy if infections are frequent Refer you to an immunologist Bottom Line IgG (Immunoglobulin G) is a vital part of your immune defense system. Abnormal levels—either too high or too low—can be a sign of chronic infection, autoimmune activity, immune deficiency, or other systemic conditions. Whether you're experiencing frequent infections or unexplained inflammation, this test offers critical insight into how your immune system is functioning and what steps may be needed next.
IgG, Quant, CSF – What It Means and Why It Matters IgG, Quant, CSF stands for Immunoglobulin G, Quantitative, Cerebrospinal Fluid. This test measures the concentration of IgG, a type of antibody, in your cerebrospinal fluid (CSF)—the clear fluid that surrounds your brain and spinal cord. What is IgG? Immunoglobulin G (IgG) is the most abundant antibody in the body. It plays a critical role in immune defense by identifying and neutralizing viruses, bacteria, and other foreign substances. IgG is normally found in the blood but can also be present in small amounts in the CSF. Why Measure IgG in CSF? This test helps detect abnormal immune activity or inflammation within the central nervous system (CNS). It's often used in the diagnostic workup of: Multiple sclerosis (MS) Chronic CNS infections (e.g., neurosyphilis, Lyme disease, viral meningitis) Autoimmune diseases affecting the brain or spinal cord Neurological complications of systemic diseases What Does a High IgG, CSF Level Mean? Elevated IgG in the CSF may suggest: Multiple sclerosis (MS) or other demyelinating diseases Chronic inflammation or immune activation in the CNS Intrathecal synthesis of IgG (i.e., the body is producing IgG within the CNS) In MS, this test is often interpreted alongside oligoclonal bands and the IgG index, which compare CSF IgG to serum IgG to determine whether the elevated antibodies are coming from within the CNS. What Does a Low IgG, CSF Level Mean? A low level of IgG in the CSF is typically not concerning on its own and may simply reflect: Normal immune activity Reduced CSF sampling or protein levels Rarely, impaired immune response in immunocompromised individuals Summary IgG, Quant, CSF is an important diagnostic tool for detecting immune activity in the brain and spinal cord. Elevated levels can signal neurological diseases such as multiple sclerosis or chronic infections. Interpretation of this marker should always be done alongside other CSF findings and clinical information.
Protecting the body against infection
Measures the IgG2 subclass of immunoglobulin G in serum.
Protecting the body against infection